A diagnostic approach to hemochromatosis

Canadian Journal of Gastroenterology

Volumn 20, Issue 8, 2006, Pages 535-540

  Tavill, Anthony S ^a   Adams, Paul C ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Hemochromatosis; HFE; Iron overload

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FERRITIN; HFE PROTEIN; IRON; TRANSFERRIN;

CHROMOSOME 6; CLINICAL FEATURE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE COURSE; EARLY DIAGNOSIS; FERRITIN BLOOD LEVEL; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; IRON BINDING CAPACITY; IRON OVERLOAD; IRON STORAGE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MASS SCREENING; MUTATIONAL ANALYSIS; PHENOTYPE; PHLEBOTOMY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 33744914697     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2006/934098     Document Type: Review

References (57)

1. Adams PC, Reboussin DM, Barton JC, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005;352:1769-78.
2. Beuder E, Felitti V, Koziol J, Ho N, Gelbart T. Penetrance of 845G-> A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-8.
3. Asberg A, Hveem K, Kruger O, Bjerve K. Persons with screening-detected haemochromatosis: As healthy as the general population? Scand J Gastroenterol 2002;37:719-24.
4. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996;13:399-408.
5. O'Neil J, Powell LW. Clinical aspects of hemochromatosis. Semin Liver Dis 2005;25:381-91.
6. Olynyk J, Cullen D, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999;341:718-24.
7. Adams PC, Valberg LS. Screening blood donors for hereditary hemochromarosis: Decision analysis model comparing genotyping to phenotyping. Am J Gastroenterol 1999;94:1593-600.
8. Phatak PD, Guzman G, Woll JE, Robeson A, Phelps CE. Cost-effectiveness of screening for hereditary hemochromatosis. Arch Intern Med 1994;154:769-76.
9. DuBois S, Kowdley K. Targeted screening for hereditary haemochromatosis in high-risk groups. Aliment Pharmacol Ther 2004;20:1-14.
10. Pietrangelo A. Hereditary hemochromatosis: A new look at an old disease. N Engl J Med 2004;350:2383-97.
11. Pietrangelo A. Non-HFE hemochromatosis. Semin Liver Dis 2005;25:450-60.
12. Tavill AS. Diagnosis and management of hemochromatosis. Hepatology 2001;33:1321-8.
13. Sheldon JH. Haemochromatosis. London: Oxford University Press, 1935:164-340.
14. Edwards CQ, Cartwright GE, Skolnick MH, Amos DB. Homozygosity for hemochromatosis: Clinical manifestations. Ann Intern Med 1980;93:519-25.
15. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-19.
16. Adams PC, Speechley M, Kertesz AE. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology 1991;101:368-72.
17. Wojcik J, Speechley M, Kertesz A, Chakrabarti S, Adams P. Natural history of C282Y homozygotes for hemochromatosis. Can J Gastroenterol 2002;16:297-302.
18. Adams PC. Hepatocellular carcinoma in hereditary hemochromatosis. Can J Gastroenterol 1993;7:37-41.
19. Asberg A, Hveem K, Thorstensen K, et al. Screening for hemochromatosis - High prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001;36:1108-15.
20. Ombiga J, Adams LA, Tang K, Trinder D, Olynyk JK. Screening for HFE and iron overload. Semin Liver Dis 2005;25:402-10.
21. Fletcher LM, Dixon JL, Purdie DM, Powell LW, Crawford DH. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology 2002;122:281-9.
22. Diwakaran HH, Befeler AS, Britton RS, Brunt EM, Bacon BR. Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection. J Hepatol 2002;36:687-91.
23. Adams PC, Bradley C, Henderson AR. Evaluation of the hepatic iron index as a diagnostic criterion in hereditary hemochromatosis. J Lab Clin Med 1997;130:509-14.
24. Crawford D, Jazwinska E, Cullen L, Powell LW. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology 1998;114:1003-8.
25. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986;6:24-9.
26. Summers KM, Halliday JW, Powell LW. Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index. Hepatology 1990;12:20-5.
27. Adams PC, Reboussin DM, Leiendecker-Foster C, et al. Comparison of the unsaturated iron binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101,168 participants in the HEIRS study. Clin Chem 2005;51:1048-52.
28. Bassett ML, Halliday JW, Ferris RA, Powell LW. Diagnosis of hemochromatosis in young subjects: Predictive accuracy of biochemical screening tests. Gastroenterology 1984;87:628-33.
29. Schmitt B, Golub R, Green R. Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: Systematic review for the American College of Physicians. Ann Intern Med 2005;143:522-36.
30. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 1988;318:1355-62.
31. McLaren CE, McLachlan GJ, Halliday JW, et al. Distribution of transferrin saturation in an Australian population: Relevance to early diagnosis of hemochromatosis. Gastroenterology 1998;114:543-9.
32. Adams PC. Non-expressing C282Y homozygotes for hemochromatosis: Minority or majority of cases? Mol Genet Metab 2000;71:81-6.
33. Brissot P, Bourel M, Herry D, et al. Assessment of liver iron content in 271 patients: A reevaluation of direct and indirect methods. Gastroenterology 1981;80:557-65.
34. Guyader D, Jacquelinet C, Moirand R, et al. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 1998;115:929-36.
35. Beaton M, Guyader D, Deugnier Y, Moirand R, Chakrabarti S, Adams P. Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis. Hepatology 2002;36:673-8.
36. Morrison ED, Brandhagen DJ, Phatak PD, et al. Serum ferritin levels predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med 2003;138:627-33.
37. Bacon B, Powell LW, Adams PC, Kresina T, Hoofnagle JH. Molecular medicine and hemochromatosis: At the crossroads. Gastroenterology 1999;116:193-207.
38. Zoller H, Cox T. Hemochromatosis: Genetic testing and clinical practice. Clin Gastroenterol Hepatol 2005;3:945-58.
39. Adams PC. Implications of genotyping of spouses to limit investigation of children in genetic hemochromatosis. Clin Genet 1998;53:176-8.
40. Adams PC, Chakrabarti S. Genotypic/phenotypic correlations in genetic hemochromarosis: Evolution of diagnostic criteria. Gastroenterology 1998;114:319-23.
41. Yamashita C, Adams PC. Natural history of the C282Y homozygote of the hemochromatosis gene (HFE) with a normal serum ferritin level. Clin Gastroenterol Hepatol 2003;1:388-91.
42. Olynyk JK, Hagan SE, Cullen DJ, Beilby J, Whittall DE. Evolution of untreated hereditary hemochromatosis in the Busselton population: A 17-year study. Mayo Clin Proc 2004;79:309-13.
43. Andersen R, Tybjaerg-Hansen A, Appleyard M, Birgens H, Nordestgaard B. Hemochromatosis mutations in the general population: Iron overload progression rate. Blood 2004;103:2914-9.
44. Hanson E, Imperatore G, Burke W. HFE gene and hereditary hemochromatosis. Am J Epidemiol 2001;154:193-206.
45. Adams PC, Passmore L, Chakrabarti S, et al. Liver diseases in participants with an elevated transferrin saturation and ferritin in the Hemochromatosis and Iron Overload Screening Study. Clin Gastroenterol Hepatol 2006;4:918-23.
46. Cadet E, Capron D, Gallet M, et al. Reverse cascade screening of newborns for hereditary haemochromatosis: A model for other late onset diseases? J Med Genet 2005;42:390-5.
47. Bacon BR, Olynyk JK, Brunt EM, Britton RS, Wolff RK. HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med 1999;130:953-62.
48. Aguilar-Martinez P, Bismuth M, Picot M, et al. Variable phenotypic presentation of iron overload in H63D homozygotes: Are gene modifiers the cause? Gut 2001;6:836-42.
49. Barton JC, Acton RT, Rivers CA, et al. Genotypic and phenotypic heterogeneity of African Americans with primary iron overload. Blood Cells Mol Dis 2003;31:310-9.
50. Power T, Adams PC. Psychosocial impact of genetic screening for hemochromatosis in population screening and referred patients. Genet Test 2001;5:107-10.
51. Stuhrmann M, Hoy L, Schmidtke J. Genotype-based screening for hereditary hemochromatosis: Attitudes toward genetic testing and psychosocial impact - A report from a German pilot study. Genet Test 2005;9:242-54.
52. Patch C, Roderick P, Rosenberg W. Comparison of genotypic and phenotypic strategies for population screening in hemochromatoisis: Assessment of anxiety, depression and perception of health. Genet Med 2005;7:550-6.
53. Anderson RT, Press N, Tucker DC, et al. Patient acceptability of genotypic testing for hemochromatosis in primary care. Genet Med 2005;7:557-63.
54. Hall MA, McEwen JE, Barton JC, et al. Concerns in a primary care population about genetic discrimination by insurers. Genet Med 2005;7:311-6.
55. Delatycki MB, Allen KJ, Nisselle AE, et al. Use of community genetic screening to prevent HFE-associated hereditary haemochromatosis. Lancet 2005;366:314-6.
56. Burt MJ, George PM, Upton JD, et al. The significance of haemochromatosis gene mutations in the general population: Implications for screening. Gut 1998;43:830-6.
57. Hover AR, McDonnell SM, Burke W. Changing the clinical management of hereditary hemochromatosis: Translating screening and early case detection strategies into clinical practice. Arch Intern Med 2004;164:957-61.